| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8658929 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2017 | 28 Pages |
Abstract
The most cost-effective DPP-4 Inhibitor was sitagliptin with metformin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
MaurÃlio de Souza Cazarim, Estael Luzia Coelho da Cruz-Cazarim, André de Oliveira Baldoni, Thais Bueno Enes dos Santos, Paula Gonçalves de Souza, Ingrid de Almeida Silva, Roberta Niriam Reis Rodrigues, Alda Cristina Franco Correa Maia,